{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-140027","form_type":"8-K","ticker":"TYRA","cik":"0001863127","company_name":"Tyra Biosciences, Inc.","filed_at":"2026-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.172507+00:00","generated_at":"2026-05-15T07:52:31.140307+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Tyra Biosciences designates VP Finance Julia Rueb as principal accounting officer","bullets":["Julia Rueb (VP Finance) appointed principal accounting officer effective April 1, 2026, succeeding CFO Alan Fuhrman.","Fuhrman continues as principal financial officer; Rueb has been with the company since 2022.","Rueb is a CPA with prior roles at SOAProjects and Ernst & Young; no family ties to directors or officers."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-140027","json":"https://secwatch.observer/filing/0001193125-26-140027.json","markdown":"https://secwatch.observer/filing/0001193125-26-140027.md","text":"https://secwatch.observer/filing/0001193125-26-140027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526140027/0001193125-26-140027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1863127/000119312526140027/d136343d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:52:31.140307+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}